
The controversy around share buybacks
Share buybacks are a strategy companies use to return excess cash to their shareholders. But recently, they’ve exploded in popularity, and that’s sparked strong discussions inside financial circles. T...
16 Aug 202318min

How Dubai is reshaping the global oil trade
For decades, the global centre for oil trading has been Geneva, Switzerland. But Russia’s war in Ukraine changed that. Sanctions have made it harder for western traders to move Russian oil. Now, trade...
9 Aug 202317min

Institutional investors take to the pitch
There’s a new club coming to women’s professional football in the United States. Next season will see the debut of Bay FC, out of northern California. Aly Wagner, a former player on the US women’s nat...
2 Aug 202320min

A different way to understand the US economy
Under “normal” circumstances, economists and analysts study a variety of specific indicators to understand what’s happening with the US economy. But lately, those indicators have been sending mixed si...
26 Juli 202322min

Macquarie’s grip on global infrastructure
About 30 years ago, an Australian investment company called Macquarie figured out how to turn public utilities into lucrative assets. This strategy helped catapult the company into the biggest infrast...
19 Juli 202320min

Frances Haugen’s lessons as a Facebook whistleblower
Frances Haugen was just another Silicon Valley tech worker until she decided to speak up about what was happening inside Facebook. Now she’s written a book about her experience titled The Power of One...
12 Juli 202322min

Best Of: Tracking the mysterious rise of a UAE company
This week, we are revisiting an episode from earlier this year about an obscure firm from the United Arab Emirates: International Holding Company’s share price has jumped 40,000 per cent in just a few...
5 Juli 202322min

How a big biotech’s start-up gamble went wrong
Illumina, the world’s biggest gene sequencing company, announced plans to buy cancer detection start-up Grail for $8bn while the biotech boom was in full swing. To Illumina, Grail looked like a potent...
28 Juni 202323min





















